SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,440 | +5.9% | 2,000 | 0.0% | 0.03% | +7.4% |
| Q2 2023 | $229,040 | -16.9% | 2,000 | 0.0% | 0.03% | -20.6% |
| Q1 2023 | $275,660 | +6.4% | 2,000 | 0.0% | 0.03% | +3.0% |
| Q4 2022 | $259,160 | +17.3% | 2,000 | 0.0% | 0.03% | +10.0% |
| Q3 2022 | $221,000 | -35.2% | 2,000 | 0.0% | 0.03% | -48.3% |
| Q4 2020 | $341,000 | +21.4% | 2,000 | 0.0% | 0.06% | +5.5% |
| Q3 2020 | $281,000 | -12.5% | 2,000 | 0.0% | 0.06% | -20.3% |
| Q2 2020 | $321,000 | +24.4% | 2,000 | 0.0% | 0.07% | +27.8% |
| Q4 2019 | $258,000 | -15.1% | 2,000 | 0.0% | 0.05% | -27.0% |
| Q2 2019 | $304,000 | +27.7% | 2,000 | 0.0% | 0.07% | +21.3% |
| Q1 2019 | $238,000 | +0.4% | 2,000 | 0.0% | 0.06% | -9.0% |
| Q4 2018 | $237,000 | -59.6% | 2,000 | -50.0% | 0.07% | -16.2% |
| Q3 2018 | $587,000 | +122.3% | 4,000 | +100.0% | 0.08% | +8.1% |
| Q2 2018 | $264,000 | – | 2,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |